MoonLake Immunotherapeutics (MLTX) offers strong investment potential with key clinical trials and upcoming FDA milestones.

Te Whatu Ora is standardising oral health data and planning to consolidate dental practice management systems to enable ...

As hospitals and health systems continue to grapple with revenue leakage and clinical denials, many are turning to innovative technologies to bridge the gap between payers and providers. Organizations ...

Beyond a cancer cell’s genetic blueprint, the expression levels of certain proteins on its surface is emerging as a collection of critical, actionable biomarkers. Instead of looking for a mutated gene ...

To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...

Conte emphasized, "2025 continues to be the year of convergence of key clinical and regulatory catalysts for Jaguar. Catalysts that we feel will be transformative in terms of the value that they bring ...

“Endotyping-informed therapy in the MRI-guided intervention arm led to a reduction in angina burden and an improvement in health-related quality of life,” reported the principal investigator Colin ...

Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated ...

There is no doubt artificial intelligence (AI) has the potential to improve access to mental health care. “One could imagine ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

New clinical data show durable remissions and long-tail survivors including >2-year complete remissions in chemotherapy- and checkpoint-refractory cancersGVHD trial launching through non-dilutive fund ...